Response of primary culture of human ovarian cancer cells to chemotherapy: In vitro individualized therapy

被引:9
作者
Kar, Rajarshi [1 ]
Sharma, Chandresh [2 ]
Sen, Sudip [2 ]
Jain, Sunesh Kumar [3 ]
Gupta, Siddhartha Dutta [4 ]
Singh, Neeta [2 ]
机构
[1] Univ Coll Med Sci, Dept Biochem, Room 234, New Delhi 110095, India
[2] All India Inst Med Sci, Dept Biochem, New Delhi, India
[3] All India Inst Med Sci, Dept Obstet & Gynecol, New Delhi, India
[4] All India Inst Med Sci, Dept Pathol, New Delhi, India
关键词
Carboplatin; curcumin; ovarian cancer; primary culture; taxol; CARCINOMA CELLS; CURCUMIN; RESISTANCE; APOPTOSIS; CHEMOSENSITIVITY; CYTOTOXICITY; PACLITAXEL; CISPLATIN; PLATINUM; BCL-2;
D O I
10.4103/0973-1482.161937
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: This study focused on whether primary cultures of ovarian cancer (OC) cells established from ascites can be used to evaluate response to chemotherapeutic agents and if curcumin could enhance the efficacy of these agents. Materials and Methods: We established five primary cultures of ascitic cells from OC patients and treated them with curcumin, carboplatin, and paclitaxel singly and in combinations. The percentage of apoptotic cells was determined by flow cytometry. Results: There was a wide variation in the response of individual primary cultures to treatment with the chemotherapeutic agents. Curcumin by itself was as good as carboplatin or paclitaxel in inducing apoptosis in the primary OC cells. Curcumin was not able to affect the carboplatin mediated cell killing. However, a combination of curcumin and paclitaxel was additive and was equally effective as a combination of carboplatin and paclitaxel. A combination of curcumin carboplatin, and paclitaxel was also found to be additive and, in fact, turned out to be the best combination that gave the highest percentage of apoptosis in vitro. Conclusion: This study highlights the fact that primary cultures of OC cells can be used to detect response to chemotherapeutic agents and help to individualize the treatment offered to OC patients.
引用
收藏
页码:1050 / 1055
页数:6
相关论文
共 22 条
[1]   Curcumin derivatives: Molecular basis of their anti-cancer activity [J].
Basile, Valentina ;
Ferrari, Erika ;
Lazzari, Sandra ;
Belluti, Silvia ;
Pignedoli, Francesca ;
Imbriano, Carol .
BIOCHEMICAL PHARMACOLOGY, 2009, 78 (10) :1305-1315
[2]   Survivin Status Affects Prognosis and Chemosensitivity in Epithelial Ovarian Cancer [J].
Chen, Lifeng ;
Liang, Lizhi ;
Yan, Xiaojian ;
Liu, Naihua ;
Gong, Lihua ;
Pan, Shishi ;
Lin, Feng ;
Zhang, Qian ;
Zhao, Hongqin ;
Zheng, Feiyun .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (02) :256-263
[3]   Can the Status of the Breast and Ovarian Cancer Susceptibility Gene 1 Product (BRCA1) Predict Response to Taxane-Based Cancer Therapy? [J].
DeLigio, J. Thomas ;
Velkova, Aneliya ;
Zorio, Diego A. R. ;
Monteiro, Alvaro N. A. .
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2009, 9 (05) :543-549
[4]   Primary culture and mRNA analysis of human ovarian cells [J].
Dunfield L.D. ;
Shepherd T.G. ;
Nachtigal M.W. .
Biological Procedures Online, 2002, 4 (1) :55-61
[5]  
Gadducci A, 2006, ANTICANCER RES, V26, P687
[6]  
Gadducci A, 2002, EUR J GYNAECOL ONCOL, V23, P390
[7]   Polymeric nanoassemblies entrapping curcumin overcome multidrug resistance in ovarian cancer [J].
Gou, Qiheng ;
Liu, Lei ;
Wang, Chunting ;
Wu, Qinjie ;
Sun, Lu ;
Yang, Xi ;
Xie, Yuxin ;
Li, Ping ;
Gong, Changyang .
COLLOIDS AND SURFACES B-BIOINTERFACES, 2015, 126 :26-34
[8]  
Huq F, 2014, ANTICANCER RES, V34, P541
[9]   Treatment of ovarian cancer beyond chemotherapy: Are we hitting the target? [J].
Ingles Garces, Alvaro Henrique ;
Fontes Dias, Mariane Sousa ;
Paulino, Eduardo ;
Moreira Ferreira, Carlos Gil ;
de Melo, Andreia Cristina .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (02) :221-234
[10]   Role of apoptotic regulators in human epithelial ovarian cancer [J].
Kar, Rajarshi ;
Sen, Sudip ;
Singh, Archna ;
Sharma, Himani ;
Kumar, Sunesh ;
Gupta, Siddhartha Dutta ;
Singh, Neeta .
CANCER BIOLOGY & THERAPY, 2007, 6 (07) :1101-1105